Skip to content

Revvity RVTY Environmental Health — Operating Income

Discontinued — last reported Q3 '16

Similar metrics at other companies

Leidos Holdings logo
LDOSHealth — Operating Income (Loss)
$147M+70.9%
Agilent Technologies logo
ALife Sciences and Applied Markets — Operating Income (Loss)
$233M-2.9%
SPX Technologies logo
SPXCHVAC — Operating Income (Loss)
$73.9M+8.0%
Element Solutions logo
ESIOperating Segments — Operating Income
$192.9M+15.0%
Kenvue logo
KVUEEssential Health — Segment adjusted operating income
$299M+25.1%
Zimmer Biomet Holdings logo
ZBHOperating Segments — Operating Income
$516.3M-1.4%

Other financials

Income statement

See full
Revenue$711.1M+7.0%
Gross profit$387.7M+3.2%
Operating income$75.9M+5.1%
Net income$40.7M-3.6%
EPS (diluted)$0.36+2.9%

Balance sheet

See full
Cash & equivalents$861.5M-24.3%
Total debt$3.9B+17.8%
Total equity$7.2B-5.9%
Total assets$12.0B-2.9%

Cash flow

See full
Operating cash flow$115.2M-10.1%
CapEx$19.8M+23.7%
Free cash flow$95.5M-14.9%

Valuation

See full
Market cap$11.16B-22.9%
Enterprise value$14.24B-13.7%
P/E46.5×-4.0×
P/S3.8×-1.4×

Profitability

See full
Gross margin48.5%
Operating margin12.4%-1.1pp
Net margin8.3%-2.1pp
FCF margin17%-1.9pp

Returns & leverage

See full
Return on equity3.2%-0.5pp
Debt / equity0.5×+0.1×
Current ratio1.7×-1.9×

Where this comes from

Reported directly by Revvity in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Revvity’s 10-Q, filed November 8, 2016, on SEC EDGAR. View the filing →

Questions, answered.

What does environmental health — operating income mean?
The profit or loss earned by the Environmental Health business unit from its day-to-day operations.
How do you interpret environmental health — operating income?
An increase indicates improved operational efficiency or higher margins; a decrease suggests rising costs or declining segment demand.
How does environmental health — operating income compare across companies?
Commonly reported as Segment Operating Income or Segment EBIT by diversified life science and industrial companies.